论文部分内容阅读
为了解凝血酶治疗支气管肺癌纤支镜活检后出血的临床疗效及安全性。将 165例支气管肺癌患者随机分为三组 ,每组 5 5例 ,在支气管镜活检前后经纤支镜分别注入凝血酶溶液 1ml或肾上腺素溶液 1ml。结果凝血酶组、肾上腺素组及两药合用组总有效率分别为 98%、79 2 %及 93 9% ,三组比较有显著性差异 (P <0 0 1) ,凝血酶组疗效明显优于肾上腺素组。
To understand the clinical efficacy and safety of thrombin in the treatment of bleeding after bronchofibroscopy biopsy. A total of 165 patients with bronchogenic carcinoma of lung were randomly divided into three groups (55 in each group), and 1 ml of thrombin solution or 1 ml of epinephrine solution were respectively injected by bronchoscopy before and after bronchoscopic biopsy. Results The total effective rate was 98%, 79 2% and 93 9% respectively in the thrombin group, epinephrine group and the combination of the two drugs groups (P <0.01), and the thrombin group was significantly better In the adrenaline group.